Species,EgKI-1-treatedmice
Disease,cancercells
Disease,significanttumorgrowthreduction
Disease,tumorgrowthreductioninmice
Disease,cancercellgrowth
Disease,tumorgrowthreductioninEgKI-1-treatedmice
Disease,tumorgrowthreduction
Species,oncosphereofcaninetapewormEchinococcus
Disease,significanttumorgrowthreductioninEgKI-1-treatedmice
Chemical,tamoxifen
Disease,ERcancer
Chemical,singletamoxifen
Chemical,co-treatmentoftamoxifen
Disease,death
Species,patient
Disease,informationofbreastresultingindetectiondiagnosisofbreastcancer
Species,healthypatientintoskinfibroglandulartissueadiposetissue
Disease,functionalinformationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT.
Disease,informationofbreastresultingindetectiondiagnosisofbreastcancerwithbreastCT.
Disease,antioxidantfree-radicalscavengingagainsthumanbreast-cancercelllines
Species,humancelllines
Disease,humanbreast-cancercelllines
Disease,free-radicalscavengingagainsthumanbreast-cancercelllines
Species,womenwithBCstreatedfrom2008to2017
Species,womenwithHER2-positiveBCstreatedwithtrastuzumabfrom2008to2017
Species,women
Species,womenwithHER2-positiveBCstreatedwithtrastuzumab
Species,twogroupsincluding196patients
Species,humanepidermalgrowthfactorreceptor2
Disease,advancedbreastcancer
Disease,T-PATappointment
Disease,breastcancer
Disease,utilizationofacidforbreastcancertherapy
Chemical,aldehydedehydrogenase
Disease,utilizationforbreastcancertherapyviadisruption
Disease,cancerprevention
Disease,novelutilizationof3-O-p-coumaroyltormenticacidforbreastcancertherapyviadisruption
Disease,breastcancercellproliferation
Disease,early-stagebreastcancer
Disease,endofRTtreatmentskintoxicity
Species,patients
Species,51.1%ofpatientsG2
Disease,ER-positive/humanepidermalgrowthfactorreceptor2-negativebreastcancer
Species,patientselection
Chemical,5yearsoftamoxifentherapywith5yearsoftamoxifen
Disease,laterecurrencesinpatientswithtumors
Species,laterecurrencesinpatients
Species,recurrencesinpatients
Disease,recurrencesinpatientswithtumors
Chemical,estrogenreceptor
Disease,patientswithtumorsshowing
Disease,tumorsshowing
Gene,HRpositivebreastcancerPI3Kinhibitors
Disease,developmentofgenerationoftargetedtherapiesforadvancedbreastcancer
Disease,developmentofnewgenerationoftargetedtherapiesforadvancedbreastcancer
Species,patientswithhormonereceptor
Chemical,selectiveestrogenreceptormodulators
Gene,treatmentofadvancedHRpositiveHER2negativebreastcancerhighlighting
Disease,lesstoxicity
Gene,HRpositivemetastaticbreastcancer
Gene,growthpathwayinHRpositivebreastcancerPI3Kinhibitors
Disease,womenwithbreastcancer
Disease,penetrationpain
Disease,penetrationpaindesirelubrication
Disease,cancer
Species,Women'sSexualFunction
Disease,514womenwithbreastcancer
Species,514women
Disease,developmentoftumors
Disease,progressionofbreastcancer
Disease,developmentofmammarytumors
Chemical,MTT
Chemical,pivotalroleofIRantagonistS961
Gene,evenpresenceofinsulin
Chemical,roleofIRantagonistS961
Chemical,roleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231
Chemical,presenceofS961
Chemical,pivotalroleofIRantagonistS961onIRsignalling
Chemical,roleofIRantagonistS961onIRsignalling
Chemical,continuedpresenceofS961
Disease,breastcancerpathogenesis
Chemical,pivotalroleofIRantagonistS961onIRsignallinginMCF-7MDA-MB-231
Gene,plasmaIL-6levels
Species,breastcancerpatients
Species,mouse
Disease,reductioninbreastcancergrowth
Disease,breastcancergrowth
Gene,CXCL1administration
Disease,breastcancerlymphnodemetastasis
Disease,breastcancermetastasis
Disease,significantreductioninbreastcancergrowth
Gene,SOX4promoter
Disease,advancedrecurrentbreastcancer
Chemical,GEM
Species,only1patientofLevel1group
Disease,metastaticbreastcancer
Species,Japanesepatientswithmetastaticbreastcancer
Disease,cancer-relateddeath
Disease,significanttumorgrowthreduction
Chemical,naringenin
Disease,Breastcancer
Chemical,naringenintreatmentgroup
Disease,tumormodels
Disease,percentcytotoxicity
Species,196patients
Species,patients
Species,women
Species,Mostpatients
Species,Patientself-reports
Species,Femalepatients
Disease,T-PATparticipants
Chemical,aldehydedehydrogenase
Chemical,estrogenreceptor
Gene,mTORinhibitoreverolimus
Chemical,selectiveestrogenreceptormodulators
Species,participants
Species,514women
Chemical,ERÎ±polyubiquitinationselectiveestrogenreceptordegraders
Chemical,ERÎ±polyubiquitinationestrogenreceptordegraders
Chemical,S961
Chemical,IRantagonistS961
Disease,breastcancercells
Gene,CXCL1silencing
Gene,highCXCL1expression
Gene,CXCL1
Gene,CXCL1expression
Species,3patients
Species,4patients
Species,otherpatients
Species,Japanesepatients